FDA product code JFY: Enzymatic Method, Creatinine
JFY is the FDA product code for enzymatic method, creatinine. It is a Class II device, regulated under 21 CFR 862.1225 and reviewed by the Clinical Chemistry panel. FDA has cleared 49 510(k) submissions under JFY, 1 in the last five years, from 37 different applicants. The average 510(k) review took 134 days (median 117); 185 days on average over the last three years. FDA has posted 29 recalls for JFY devices.
Classification
| Field | Value |
|---|---|
| Device name | Enzymatic Method, Creatinine |
| Device class | Class II |
| Regulation | 21 CFR 862.1225 |
| Review panel | CH — Clinical Chemistry |
| Medical specialty | Clinical Chemistry |
| Premarket route | 510(k) |
| Third-party 510(k) review eligible | Yes |
510(k) clearances per year for JFY
| Year | Clearances | Avg. review days |
|---|---|---|
| 2017 | 1 | 414 |
| 2018 | 2 | 112 |
| 2019 | 2 | 194 |
| 2021 | 2 | 314 |
| 2026 | 1 | 185 |
Compare with all 510(k) review times · Search every JFY clearance
Top JFY applicants
| Applicant | Clearances | Latest |
|---|---|---|
| Ortho-Clinical Diagnostics, Inc. | 5 | 2018-10-30 |
| Boehringer Mannheim Corp. | 4 | 1991-08-12 |
| Siemens Healthcare Diagnostics, Inc. | 2 | 2021-11-24 |
| HORIBA ABX SAS | 2 | 2021-05-10 |
| Teco Diagnostics, Inc. | 2 | 2017-07-21 |
32 more applicants have JFY clearances. See the full list in Caduvo.
Most recent JFY clearances
| 510(k) | Applicant | Device | Decision date | Review days |
|---|---|---|---|---|
| K252619 | Qstag, Inc. | QSCHECK UISACR | 2026-02-20 | 185 |
| K212223 | Siemens Healthcare Diagnostics, Inc. | Atellica CH Enzymatic Creatinine_3 (ECre3) | 2021-11-24 | 131 |
| K193649 | HORIBA ABX SAS | Yumizen C1200 Creatinine PAP | 2021-05-10 | 497 |
| K182384 | Healthy.Io, Ltd. | ACR LAB Urine Analysis Test System | 2019-07-26 | 329 |
| K183555 | Instrumentation Laboratory CO | GEM Premier ChemSTAT | 2019-02-16 | 58 |
Recalls for JFY devices
29 product recalls in 20 recall events; 0 initiated in the last five years and 0 still open. Most recent: 2020-07-13.
| Year | Recalls |
|---|---|
| 2017 | 2 |
| 2018 | 1 |
| 2019 | 5 |
| 2020 | 5 |
Frequently asked questions
What is FDA product code JFY?
JFY is the FDA product code for enzymatic method, creatinine. It is a Class II device, regulated under 21 CFR 862.1225 and reviewed by the Clinical Chemistry panel.
What device class is JFY?
Class II, regulation 21 CFR 862.1225. Typical premarket route: 510(k).
How long does a 510(k) take for product code JFY?
Across 49 cleared submissions the average was 134 days from receipt to decision (median 117).
Which companies have the most JFY clearances?
Ortho-Clinical Diagnostics, Inc. (5); Boehringer Mannheim Corp. (4); Siemens Healthcare Diagnostics, Inc. (2); HORIBA ABX SAS (2); Teco Diagnostics, Inc. (2).
Have JFY devices been recalled?
Yes: 29 product recalls across 20 recall events; the most recent began 2020-07-13.
Next steps
- Run an FDA pathway report with predicate devices for product code JFY
- Run a recall and safety report across every JFY manufacturer
- Watch product code JFY for new clearances and recalls
Compiled by Caduvo from public U.S. FDA records. Applicant names are shown as FDA records them. Review days run from FDA receipt to decision. Not reviewed or endorsed by FDA. Not regulatory advice. Report an error. Data and corrections policy.
All Clinical Chemistry product codes · FDA product code lookup · 510(k) database search · 510(k) review times